Skip to main
HAE
HAE logo

Haemonetics (HAE) Earnings Dates & Reports

Haemonetics (HAE) Most Recent Earnings

Report DateMay 8, 2025
Period EndingQ4 2025
Est. EPS$1.22
Actual EPS$1.24
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Haemonetics (HAE) Earnings per Share (EPS) History

Signup for full access
Browse free

Haemonetics (HAE) Latest Earnings

The value each HAE share was expected to gain vs. the value each share gained.

Haemonetics (HAE) reported its most recent earnings on May 8, 2025 for Q4 2025, posting earnings per share (EPS) of $1.24. This exceeded analysts' expectations of $1.22 by 1.64%, marking a Beat.

For comparison, Haemonetics reported EPS of $0.90 in the same quarter last year.

The company is expected to announce its next earnings report on 08/07/2025, with analysts projecting an EPS of $1.02.

Haemonetics (HAE) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q1 2026Aug 7, 2025
$1.02Next earnings call Aug. 7, 2025
Q4 2025May 8, 2025
$1.22$1.24+1.64%
DeckReportListen
Q3 2025Feb 6, 2025
$1.17$1.19+1.71%
Q2 2025Nov 7, 2024
$1.07$1.12+4.67%
Q1 2025Aug 8, 2024
$1.00$1.02+2.00%
View all

Haemonetics (HAE) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Haemonetics’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
May 8, 2025
Feb 6, 2025
Nov 7, 2024
Aug 8, 2024

Haemonetics (HAE) Earnings FAQs

Haemonetics (HAE) last reported earnings on May 8, 2025 for Q4 2025, posting an EPS of $1.24, which Beat the estimate of $1.22 by 1.64%.

For Q4 2025, Haemonetics (HAE) reported an EPS of $1.24, exceeding analysts' estimate of $1.22 by 1.64%.

For Q4 2025, Haemonetics (HAE) Beat expectations with an actual EPS of $1.24 vs. an estimated EPS of $1.22.

Following the last earnings report on May 8, 2025, Haemonetics (HAE)'s stock price moved — from — to —.

The next Haemonetics (HAE) earnings call is scheduled for Aug. 7, 2025, where executives will discuss financial results and outlook.

Haemonetics (HAE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.